Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Microsoft
MSFT
|
$7.54B |
| 2 |
Apple
AAPL
|
$5.11B |
| 3 |
Amazon
AMZN
|
$2.93B |
| 4 |
UnitedHealth
UNH
|
$2.83B |
| 5 |
Alphabet (Google) Class C
GOOG
|
$2.75B |
Top Sells
| 1 |
ZEN
ZENDESK INC
ZEN
|
$330M |
| 2 |
Snap
SNAP
|
$321M |
| 3 |
Twilio
TWLO
|
$309M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$156M |
| 5 |
AVLR
Avalara, Inc.
AVLR
|
$154M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Jazz Pharmaceuticals
JAZZ
$7.77B
| $330M | 0.12% |
2,477,800
+1,341,765
| +118% | +$179M |
|
177
Walker & Dunlop
WD
$2.84B
| $329M | 0.12% |
3,926,842
+1,946,557
| +98% | +$163M |
|
178
Schwab US Large- Cap ETF
SCHX
$59.3B
| $324M | 0.12% |
+22,942,620
| New | +$324M |
|
179
Cisco
CSCO
$269B
| $323M | 0.12% |
8,078,092
+5,222,490
| +183% | +$209M |
|
180
Pfizer
PFE
$140B
| $319M | 0.12% |
7,296,738
+3,963,681
| +119% | +$173M |
|
181
Sempra
SRE
$53.6B
| $318M | 0.12% |
4,241,112
+1,901,730
| +81% | +$143M |
|
182
Ryan Specialty Holdings
RYAN
$7.04B
| $316M | 0.12% |
7,791,626
+3,900,380
| +100% | +$158M |
|
183
Automatic Data Processing
ADP
$122B
| $315M | 0.12% |
1,391,238
+676,396
| +95% | +$153M |
|
184
Berkshire Hathaway Class B
BRK.B
$1.09T
| $310M | 0.12% |
1,160,036
+762,301
| +192% | +$204M |
|
185
Amicus Therapeutics
FOLD
$2.47B
| $309M | 0.12% |
29,552,230
+12,772,089
| +76% | +$133M |
|
186
Roper Technologies
ROP
$56.7B
| $306M | 0.11% |
850,126
+445,392
| +110% | +$160M |
|
187
Magnolia Oil & Gas
MGY
$4.56B
| $303M | 0.11% |
15,277,432
+6,571,670
| +75% | +$130M |
|
188
TSMC
TSM
$1.22T
| $302M | 0.11% |
4,391,790
-861,936
| -16% | -$59.2M |
|
189
Elanco Animal Health
ELAN
$8.68B
| $299M | 0.11% |
24,113,392
+12,151,843
| +102% | +$151M |
|
190
Carlisle Companies
CSL
$16.8B
| $297M | 0.11% |
1,059,342
+460,901
| +77% | +$129M |
|
191
Occidental Petroleum
OXY
$45.9B
| $296M | 0.11% |
4,813,136
+2,392,742
| +99% | +$147M |
|
192
Rockwell Automation
ROK
$38.4B
| $295M | 0.11% |
1,369,506
+641,067
| +88% | +$138M |
|
193
Salesforce
CRM
$232B
| $293M | 0.11% |
2,034,356
+1,075,588
| +112% | +$155M |
|
194
Burlington
BURL
$19B
| $292M | 0.11% |
2,613,270
+729,287
| +39% | +$81.6M |
|
|
TWNK
195
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $291M | 0.11% |
12,539,924
+6,271,193
| +100% | +$146M |
|
196
Akero Therapeutics
AKRO
$3.52B
| $291M | 0.11% |
8,550,918
+5,482,606
| +179% | +$187M |
|
197
Snowflake
SNOW
$74B
| $285M | 0.11% |
1,678,630
+336,312
| +25% | +$57.2M |
|
198
Cognizant
CTSH
$34.9B
| $283M | 0.11% |
4,934,888
+2,726,196
| +123% | +$157M |
|
199
Integra LifeSciences
IART
$1.22B
| $269M | 0.1% |
6,345,076
+3,064,928
| +93% | +$130M |
|
200
Yum China
YUMC
$16.4B
| $268M | 0.1% |
5,663,400
+3,330,464
| +143% | +$158M |
|